Climb Bio, INC. 8-K Filing
Ticker: CLYM · Form: 8-K · Filed: Dec 11, 2025 · CIK: 1768446
| Field | Detail |
|---|---|
| Company | Climb Bio, INC. (CLYM) |
| Form Type | 8-K |
| Filed Date | Dec 11, 2025 |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Climb Bio, INC. (ticker: CLYM) to the SEC on Dec 11, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ich registered Common Stock, par value $0.0001 per share CLYM The Nasdaq Stock Mar).
How long is this filing?
Climb Bio, INC.'s 8-K filing is 4 pages with approximately 1,085 words. Estimated reading time is 4 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,085 words · 4 min read · ~4 pages · Grade level 12.4 · Accepted 2025-12-11 08:16:07
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CLYM The Nasdaq Stock Mar
Filing Documents
- d48098d8k.htm (8-K) — 32KB
- d48098dex41.htm (EX-4.1) — 78KB
- d48098dex101.htm (EX-10.1) — 32KB
- 0001193125-25-315108.txt ( ) — 290KB
- clym-20251211.xsd (EX-101.SCH) — 3KB
- clym-20251211_lab.xml (EX-101.LAB) — 18KB
- clym-20251211_pre.xml (EX-101.PRE) — 11KB
- d48098d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 4.1 Form of Pre-Funded Warrant 10.1 Exchange Agreement 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Climb Bio, Inc. Date: December 11, 2025 By: /s/ Aoife Brennan Aoife Brennan, M.B., Ch.B. President and Chief Executive Officer